|
業務類別
|
Biotechnology |
|
業務概覽
|
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases. |
| 公司地址
| 3580 Carmel Mountain Road, Suite 200, San Diego, CA, USA, 92130 |
| 電話號碼
| +1 877 245-2787 |
| 傳真號碼
| +1 858 614-7007 |
| 公司網頁
| https://www.connectbiopharm.com |
| 員工數量
| 64 |
| Mr. Raul Collazo, PhD |
Vice President, Global Head of Medical Affairs and Strategy |
-- |
31/03/2026 |
| Dr. Lei Sun, PhD |
Vice President, Biologics and Head of CMC |
-- |
31/03/2026 |
| Mr. David Szekeres |
President |
美元 508.40K |
31/03/2026 |
| Mr. Jeff Cohn, J.D. |
General Counsel and Corporate Secretary |
-- |
31/03/2026 |
| Dr. Barry D. Quart,Pharm.D. |
Chief Executive Officer and Director |
美元 660.80K |
31/03/2026 |
| Ms. Kimberly J. Manhard |
Executive Vice President and Chief Development Officer |
-- |
31/03/2026 |
| Ms. Lisa Peraza |
Senior Vice President, Finance |
美元 414.62K |
31/03/2026 |
| Mr. Sean T. Ristine |
Vice President, Human Resources |
-- |
31/03/2026 |
|
|
| Mr. James A. Schoeneck |
Independent Director |
31/03/2026 |
| Dr. Kleanthis G. Xanthopoulos,PhD |
Chairman of the Board |
31/03/2026 |
| Mr. James Z. Huang |
Independent Director |
31/03/2026 |
| Dr. Barry D. Quart,Pharm.D. |
Chief Executive Officer and Director |
31/03/2026 |
| Ms. Karen J. Wilson |
Independent Director |
31/03/2026 |
| Ms. Jean I. Liu, J.D. |
Independent Director |
31/03/2026 |
|
|
|
|
